Use of Recombinant TSH in the Treatment and Monitoring of Well-Differentiated Thyroid Cancers

Journal Title: Nuclear Medicine Seminars - Year 2021, Vol 7, Issue 1

Abstract

Differentiated thyroid cancer (DTC) is an endocrine tumour with mostly good prognosis that requires life long followup. Primary treatments are total thyroidectomy (TT) and radioactive iodine (RAI) therapy. Complete removal of thyroid tissue with TT and RAI causes serum thyroglobuline (Tg) levels to fall to undetectable levels. Thyroid stimulating hormone (TSH) levels have an important role both in preparation for RAI and detection of disease status with stimulated Tg levels in the follow-up. Recently, recombinant human TSH (rhTSH) usage has been incorporated to our clinical practice in I-131 whole body scintigraphy and/or measurement of serum Tg levels and in preparation for RAI ablation. In this review, clinical applications of rhTSH in the therapy and follow-up of DTC will be focused on.

Authors and Affiliations

Elgin Özkan, Mine Araz

Keywords

Related Articles

Imaging Guideline in Pediatric Neuroblastoma Patients

The aim of this procedure guideline is the standardization of I-123 metaiodobenzylguanidine scintigraphy, F-18 fluorodeoxyglucose, F-18 fluoropheniylalanine, Ga-68 DOTA peptide positron emission tomography/computerized t...

Early and Late Side Effects and Patient Management in I-131 Treatment

I-131 is the first most experienced theranostic radionuclide that has been used since the early 1940s for the treatment of hyperthyroidism, metastases or ablation of residual thyroid tissue in well-differentiated thyroid...

Guidelines for Myocardial Viability Imaging with F-18 FDG

Myocardial viability imaging with Fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT), in patients who are appropriate for coronary revascularization, in the presence of le...

Practical Guidance on Peptide Receptor Radionuclide Therapy

Peptide receptor radionuclide therapy (PRRT) have been successfully used for the past 20 years to target metastatic or inoperable neuroendocrine tumors expressing the somatostatin receptors. Both prospective and retrospe...

Procedure Guideline for Lymphoscintigraphy and Sentinel Lymph Node: Malignant Melanoma

Malignant melanoma is still among the most fatal cancers worldwide with increasing incidence. Lymphoscintigraphy and gamma probe guided sentinel lymph node detection is an established procedure which has a great impact i...

Download PDF file
  • EP ID EP693444
  • DOI 10.4274/nts.galenos.2021.0010
  • Views 101
  • Downloads 0

How To Cite

Elgin Özkan, Mine Araz (2021). Use of Recombinant TSH in the Treatment and Monitoring of Well-Differentiated Thyroid Cancers. Nuclear Medicine Seminars, 7(1), -. https://europub.co.uk/articles/-A-693444